325 related articles for article (PubMed ID: 12426633)
1. CCR5 genotype and plasma beta-chemokine concentration of Brazilian HIV-infected individuals.
Mikawa AY; Tagliavini SA; Costa PI
Braz J Med Biol Res; 2002 Nov; 35(11):1333-7. PubMed ID: 12426633
[TBL] [Abstract][Full Text] [Related]
2. Heterozygous defect in HIV-1 coreceptor CCR5 and chemokine production.
Yang JY; Togni M; Widmer U
Cytokine; 1999 Jan; 11(1):1-7. PubMed ID: 10080873
[TBL] [Abstract][Full Text] [Related]
3. Heterozygosity for a defective gene for CC chemokine receptor 5 is not the sole determinant for the immunologic and virologic phenotype of HIV-infected long-term nonprogressors.
Cohen OJ; Vaccarezza M; Lam GK; Baird BF; Wildt K; Murphy PM; Zimmerman PA; Nutman TB; Fox CH; Hoover S; Adelsberger J; Baseler M; Arthos J; Davey RT; Dewar RL; Metcalf J; Schwartzentruber DJ; Orenstein JM; Buchbinder S; Saah AJ; Detels R; Phair J; Rinaldo C; Margolick JB; Pantaleo G; Fauci AS
J Clin Invest; 1997 Sep; 100(6):1581-9. PubMed ID: 9294127
[TBL] [Abstract][Full Text] [Related]
4. The beta-chemokines MIP-1alpha and RANTES and lipoprotein metabolism in HIV-infected Brazilian patients.
Mikawa AY; Malavazi I; Tagliavini SA; Abrão EP; da Costa PI
Braz J Infect Dis; 2005 Aug; 9(4):315-23. PubMed ID: 16270124
[TBL] [Abstract][Full Text] [Related]
5. CCR5 and CXCR4 chemokine receptor expression and beta-chemokine production during early T cell repopulation induced by highly active anti-retroviral therapy.
Giovannetti A; Ensoli F; Mazzetta F; De Cristofaro M; Pierdominici M; Muratori DS; Fiorelli V; Aiuti F
Clin Exp Immunol; 1999 Oct; 118(1):87-94. PubMed ID: 10540164
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1alpha, MIP-1beta, and SDF-1.
Xiang J; George SL; Wünschmann S; Chang Q; Klinzman D; Stapleton JT
Lancet; 2004 Jun; 363(9426):2040-6. PubMed ID: 15207954
[TBL] [Abstract][Full Text] [Related]
7. Changes in CCR5 and CXCR4 expression and beta-chemokine production in HIV-1-infected patients treated with highly active antiretroviral therapy.
Pierdominici M; Giovannetti A; Ensoli F; Mazzetta F; Marziali M; De Cristofaro MR; Santini-Muratori D; Leti W; Aiuti F
J Acquir Immune Defic Syndr; 2002 Feb; 29(2):122-31. PubMed ID: 11832680
[TBL] [Abstract][Full Text] [Related]
8. Concentrations of circulating beta-chemokines do not correlate with viral load in human immunodeficiency virus-infected individuals.
Kakkanaiah VN; Ojo-Amaize EA; Peter JB
Clin Diagn Lab Immunol; 1998 Jul; 5(4):499-502. PubMed ID: 9665956
[TBL] [Abstract][Full Text] [Related]
9. Increased Levels of Macrophage Inflammatory Proteins Result in Resistance to R5-Tropic HIV-1 in a Subset of Elite Controllers.
Walker WE; Kurscheid S; Joshi S; Lopez CA; Goh G; Choi M; Barakat L; Francis J; Fisher A; Kozal M; Zapata H; Shaw A; Lifton R; Sutton RE; Fikrig E
J Virol; 2015 May; 89(10):5502-14. PubMed ID: 25740989
[TBL] [Abstract][Full Text] [Related]
10. Limited expression of R5-tropic HIV-1 in CCR5-positive type 1-polarized T cells explained by their ability to produce RANTES, MIP-1alpha, and MIP-1beta.
Annunziato F; Galli G; Nappi F; Cosmi L; Manetti R; Maggi E; Ensoli B; Romagnani S
Blood; 2000 Feb; 95(4):1167-74. PubMed ID: 10666186
[TBL] [Abstract][Full Text] [Related]
11. Anti-MIP-1alpha and anti-RANTES antibodies: new allies of HIV-1?
Kissler S; Süsal C; Opelz G
Clin Immunol Immunopathol; 1997 Sep; 84(3):338-41. PubMed ID: 9281393
[TBL] [Abstract][Full Text] [Related]
12. Lack of good correlation of serum CC-chemokine levels with human immunodeficiency virus-1 disease stage and response to treatment.
Ye P; Kazanjian P; Kunkel SL; Kirschner DE
J Lab Clin Med; 2004 May; 143(5):310-9. PubMed ID: 15122175
[TBL] [Abstract][Full Text] [Related]
13. Circulating levels and ex vivo production of beta-chemokines, interferon gamma, and interleukin 2 in advanced human immunodeficiency virus type 1 infection: the effect of protease inhibitor therapy.
De Luca A; Giancola ML; Cingolani A; Ammassari A; Murri R; Antinori A
AIDS Res Hum Retroviruses; 2000 Jun; 16(9):835-43. PubMed ID: 10875609
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal analysis of serum chemokine levels in the course of HIV-1 infection.
Polo S; Veglia F; Malnati MS; Gobbi C; Farci P; Raiteri R; Sinicco A; Lusso P
AIDS; 1999 Mar; 13(4):447-54. PubMed ID: 10197372
[TBL] [Abstract][Full Text] [Related]
15. Change in circulating levels of the chemokines macrophage inflammatory proteins 1 alpha and 11 beta, RANTES, monocyte chemotactic protein-1 and interleukin-16 following treatment of severely immunodeficient HIV-infected individuals with indinavir.
Bisset LR; Rothen M; Joller-Jemelka HI; Dubs RW; Grob PJ; Opravil M
AIDS; 1997 Mar; 11(4):485-91. PubMed ID: 9084796
[TBL] [Abstract][Full Text] [Related]
16. Highly active antiretroviral therapy normalizes the potential for MIP-1alpha production in HIV infection.
Carter LM; Peters BS; Ellis BA; Wolstencroft RA
J Infect; 2000 Nov; 41(3):252-5. PubMed ID: 11120614
[TBL] [Abstract][Full Text] [Related]
17. Endogenous production of beta-chemokines by CD4+, but not CD8+, T-cell clones correlates with the clinical state of human immunodeficiency virus type 1 (HIV-1)-infected individuals and may be responsible for blocking infection with non-syncytium-inducing HIV-1 in vitro.
Saha K; Bentsman G; Chess L; Volsky DJ
J Virol; 1998 Jan; 72(1):876-81. PubMed ID: 9420304
[TBL] [Abstract][Full Text] [Related]
18. Expression of chemokine receptors CCR5 and CXCR4 on CD4+ T cells and plasma chemokine levels during treatment of active tuberculosis in HIV-1-coinfected patients.
Wolday D; Tegbaru B; Kassu A; Messele T; Coutinho R; van Baarle D; Miedema F
J Acquir Immune Defic Syndr; 2005 Jul; 39(3):265-71. PubMed ID: 15980685
[TBL] [Abstract][Full Text] [Related]
19. Activation of beta-chemokines and CCR5 in persons infected with human immunodeficiency virus type 1 and tuberculosis.
Mayanja-Kizza H; Wajja A; Wu M; Peters P; Nalugwa G; Mubiru F; Aung H; Vanham G; Hirsch C; Whalen C; Ellner J; Toossi Z
J Infect Dis; 2001 Jun; 183(12):1801-4. PubMed ID: 11372034
[TBL] [Abstract][Full Text] [Related]
20. Endogenous levels of C-C chemokines MIP-1alpha, MIP-1beta, and RANTES do not reflect the disease course in HIV-seropositive individuals.
Kreuzer KA; Rockstroh JK; Kupfer B; Spengler U
Int J Clin Lab Res; 2000; 30(4):163-8. PubMed ID: 11289705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
